Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02205333 | A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies(MEDI6469) | terminated | Phase 1 / Phase 2 | 48 | MedImmune LLCINDUSTRY | 1 | Jun 28, 2017 | clinicaltrials |
| NCT00977067 | A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies | terminated | Phase 1 | 40 | Genentech, Inc.INDUSTRY | 0 | Jun 21, 2017 |
| clinicaltrials |
| NCT00728429 | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | terminated | N/A | 1 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01893879 | Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema(PCTTPL) | terminated | N/A | 14 | Stanford UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT00217724 | Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer | terminated | N/A | 18 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00258440 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | terminated | N/A | 7 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01031953 | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 1 / Phase 2 | 34 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01453387 | MSC2015103B in Solid Tumors | terminated | Phase 1 | 28 | EMD SeronoINDUSTRY | 1 | May 8, 2017 | clinicaltrials |
| NCT02040558 | Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors | terminated | Phase 1 | 44 | MallinckrodtINDUSTRY | 1 | Apr 5, 2017 | clinicaltrials |
| NCT01098643 | Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors | terminated | N/A | 88 | Vanderbilt UniversityOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT01516645 | Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 14 | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Mar 16, 2017 | clinicaltrials |
| NCT01299701 | A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors | terminated | Phase 1 | 7 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 14, 2017 | clinicaltrials |
| NCT01504490 | Phase I Study of CS-7017 and Bexarotene | terminated | Phase 1 | 9 | Georgetown UniversityOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00585221 | Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients | terminated | Phase 2 | 8 | University of UtahOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT00019604 | Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer | terminated | Phase 2 | 44 | National Institutes of Health Clinical Center (CC)NIH | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00550654 | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | terminated | Phase 2 | 1 | National Institutes of Health Clinical Center (CC)NIH | 1 | Jan 13, 2017 | clinicaltrials |
| NCT00996892 | Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors | terminated | Phase 1 | 178 | Genentech, Inc.INDUSTRY | 1 | Dec 30, 2016 | clinicaltrials |
| NCT01204450 | Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma | terminated | Phase 1 | 7 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 23, 2016 | clinicaltrials |
| NCT00359671 | Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001) | terminated | Phase 1 | 38 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 29, 2016 | clinicaltrials |
| NCT02895490 | Communication Training in Promoting Employment Retention Among Cancer Patients | terminated | N/A | 8 | Virginia Commonwealth UniversityOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT00944372 | Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors | terminated | Phase 4 | 150 | MallinckrodtINDUSTRY | 1 | Sep 9, 2016 | clinicaltrials |
| NCT00938457 | Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | terminated | Phase 1 / Phase 2 | 3 | Mayo ClinicOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT00512460 | RTA 744 Injection in Patients With Leptomeningeal Disease | terminated | Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT00634010 | Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain | terminated | Phase 3 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2016 | clinicaltrials |
| NCT01930292 | Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies | terminated | Phase 1 | 31 | Debiopharm International SAINDUSTRY | 1 | Mar 24, 2016 | clinicaltrials |
| NCT00632424 | Phase 1 Trial of Oral Ixabepilone | terminated | Phase 1 | 23 | R-PharmINDUSTRY | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00664586 | A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors | terminated | Phase 1 | 21 | Erimos PharmaceuticalsINDUSTRY | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01497626 | Lapatinib and Bortezomib in Patients With Advanced Malignancies | terminated | Phase 1 | 15 | Georgetown UniversityOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT02096341 | A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 | terminated | Phase 1 | 2 | EpicentRx, Inc.INDUSTRY | 1 | Jan 21, 2016 | clinicaltrials |
| NCT01093092 | Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | terminated | Phase 1 | 14 | Roswell Park Cancer InstituteOTHER | 1 | Jan 12, 2016 | clinicaltrials |
| NCT01809912 | Safety Study of MG1102 in Patients With Solid Tumors | terminated | Phase 1 | 16 | Green Cross CorporationINDUSTRY | 1 | Nov 26, 2015 | clinicaltrials |
| NCT00982657 | A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma | terminated | Phase 2 | 34 | PfizerINDUSTRY | 1 | Nov 20, 2015 | clinicaltrials |
| NCT01004822 | A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors | terminated | Phase 1 | 31 | PfizerINDUSTRY | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00704938 | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer | terminated | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 28, 2015 | clinicaltrials |
| NCT00932126 | This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors | terminated | Phase 1 | 35 | PfizerINDUSTRY | 2 | Oct 28, 2015 | clinicaltrials |
| NCT00360867 | An Open Label Treatment Extension Study of AMG 706 | terminated | Phase 2 | 94 | AmgenINDUSTRY | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00546247 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) | terminated | Phase 1 / Phase 2 | 26 | Bristol-Myers SquibbINDUSTRY | 2 | Oct 12, 2015 | clinicaltrials |
| NCT00550017 | A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) | terminated | Phase 1 / Phase 2 | 39 | Bristol-Myers SquibbINDUSTRY | 3 | Oct 12, 2015 | clinicaltrials |
| NCT00486213 | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer | terminated | Phase 3 | 210 | National Cancer Centre, SingaporeOTHER | 1 | Sep 24, 2015 | clinicaltrials |
| NCT00598091 | A Phase I/Expansion Study of Dasatinib(Gem/Dsat) | terminated | Phase 1 | 30 | Duke UniversityOTHER | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00099346 | MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001) | terminated | Phase 1 | — | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 17, 2015 | clinicaltrials |
| NCT01846429 | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | terminated | Phase 1 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT00951158 | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | terminated | Phase 1 | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT01122888 | Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme | terminated | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00278018 | Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors | terminated | Phase 1 / Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01081808 | Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | terminated | Phase 1 | 2 | Roger Williams Medical CenterOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT01324115 | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 6 | Cancer Research UKOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01137552 | A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors | terminated | Phase 1 | 44 | AmgenINDUSTRY | 1 | Mar 4, 2015 | clinicaltrials |
| NCT02049281 | A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) | terminated | Phase 1 | 3 | EndocyteINDUSTRY | 0 | Feb 10, 2015 | clinicaltrials |
| NCT01417403 | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases | terminated | Phase 1 | 10 | Virginia Commonwealth UniversityOTHER | 1 | Feb 3, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Jun 28, 2017source: clinicaltrials